HDAC9 and Friedreich ataxia: In fact, several compounds, such as the 2-aminobenzamide HDAC inhibitor 109 and nicotinamide, have shown interesting outcomes reversing the FXN gene silencing in cell and mouse models of FRDA (Sandi et al., 2011; Chutake et al., 2016).